| 000 | 01843 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515070318.0 | ||
| 264 | 0 | _c20070815 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1470-8728 | ||
| 024 | 7 |
_a10.1042/BJ20070296 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoukos, Georgios | |
| 245 | 0 | 0 |
_aNaturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. _h[electronic resource] |
| 260 |
_bThe Biochemical journal _cAug 2007 |
||
| 300 |
_a167-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter 1 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xmetabolism |
| 650 | 0 | 4 | _aAdenoviridae |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xblood |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCholesterol _xmetabolism |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoproteins _xchemistry |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xchemistry |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMutant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPhosphatidylcholine-Sterol O-Acyltransferase _xgenetics |
| 700 | 1 | _aChroni, Angeliki | |
| 700 | 1 | _aDuka, Adelina | |
| 700 | 1 | _aKardassis, Dimitris | |
| 700 | 1 | _aZannis, Vassilis I | |
| 773 | 0 |
_tThe Biochemical journal _gvol. 406 _gno. 1 _gp. 167-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1042/BJ20070296 _zAvailable from publisher's website |
| 999 |
_c17051152 _d17051152 |
||